Express Scripts Holding Company (ESRX) Receives Average Recommendation of “Hold” from Analysts

Shares of Express Scripts Holding Company (NASDAQ:ESRX) have earned an average rating of “Hold” from the twenty-five analysts that are covering the company, MarketBeat.com reports. Seven analysts have rated the stock with a sell rating, ten have assigned a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $69.67.

ESRX has been the topic of several recent research reports. Jefferies Group set a $72.00 price target on shares of Express Scripts and gave the stock a “buy” rating in a research report on Tuesday, August 29th. Mizuho set a $67.00 price target on shares of Express Scripts and gave the stock a “hold” rating in a research report on Tuesday, October 24th. Royal Bank Of Canada initiated coverage on shares of Express Scripts in a research report on Tuesday, September 19th. They issued a “sector perform” rating and a $68.00 price target on the stock. UBS downgraded shares of Express Scripts from a “market perform” rating to an “underperform” rating in a research report on Monday, October 9th. Finally, BidaskClub downgraded shares of Express Scripts from a “sell” rating to a “strong sell” rating in a research report on Friday, August 4th.

In other Express Scripts news, CEO Timothy C. Wentworth acquired 8,000 shares of the company’s stock in a transaction on Tuesday, October 31st. The stock was acquired at an average cost of $61.13 per share, with a total value of $489,040.00. Following the purchase, the chief executive officer now directly owns 98,628 shares of the company’s stock, valued at approximately $6,029,129.64. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Woodrow A. Myers, Jr. sold 3,900 shares of Express Scripts stock in a transaction on Monday, September 11th. The stock was sold at an average price of $63.93, for a total transaction of $249,327.00. Following the completion of the transaction, the director now directly owns 11,500 shares of the company’s stock, valued at $735,195. The disclosure for this sale can be found here. Insiders have sold 5,121 shares of company stock valued at $325,920 over the last ninety days. 0.68% of the stock is currently owned by corporate insiders.

Several large investors have recently modified their holdings of the business. Park National Corp OH grew its stake in shares of Express Scripts by 0.3% in the 2nd quarter. Park National Corp OH now owns 3,575 shares of the company’s stock worth $228,000 after buying an additional 11 shares in the last quarter. Parkside Financial Bank & Trust boosted its stake in shares of Express Scripts by 0.3% during the 2nd quarter. Parkside Financial Bank & Trust now owns 8,634 shares of the company’s stock worth $551,000 after purchasing an additional 23 shares during the period. Carroll Financial Associates Inc. boosted its stake in shares of Express Scripts by 1.0% during the 2nd quarter. Carroll Financial Associates Inc. now owns 3,186 shares of the company’s stock worth $203,000 after purchasing an additional 30 shares during the period. CAPROCK Group Inc. boosted its stake in shares of Express Scripts by 0.9% during the 2nd quarter. CAPROCK Group Inc. now owns 3,675 shares of the company’s stock worth $235,000 after purchasing an additional 33 shares during the period. Finally, Sandy Spring Bank boosted its stake in shares of Express Scripts by 0.6% during the 2nd quarter. Sandy Spring Bank now owns 6,464 shares of the company’s stock worth $413,000 after purchasing an additional 37 shares during the period. 88.44% of the stock is owned by institutional investors and hedge funds.

Express Scripts (NASDAQ:ESRX) traded up $2.32 on Friday, reaching $65.18. 7,745,500 shares of the company’s stock traded hands, compared to its average volume of 4,093,878. The company has a quick ratio of 0.61, a current ratio of 0.73 and a debt-to-equity ratio of 0.86. Express Scripts has a fifty-two week low of $55.80 and a fifty-two week high of $77.50. The company has a market capitalization of $36,920.00, a P/E ratio of 8.98, a PEG ratio of 0.91 and a beta of 0.88.

Express Scripts (NASDAQ:ESRX) last released its quarterly earnings results on Tuesday, October 24th. The company reported $1.90 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $1.90. Express Scripts had a net margin of 3.64% and a return on equity of 25.46%. The business had revenue of $24.68 billion for the quarter, compared to the consensus estimate of $25.68 billion. During the same period last year, the firm earned $1.74 earnings per share. The company’s quarterly revenue was down 2.9% on a year-over-year basis. research analysts expect that Express Scripts will post 7.01 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “Express Scripts Holding Company (ESRX) Receives Average Recommendation of “Hold” from Analysts” was first published by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another website, it was stolen and reposted in violation of US and international copyright & trademark laws. The correct version of this news story can be accessed at https://www.americanbankingnews.com/2017/12/01/express-scripts-holding-company-esrx-receives-average-recommendation-of-hold-from-analysts.html.

About Express Scripts

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Analyst Recommendations for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply